Similarly, the viability of three other human AML cell lines (NB4, OCI/AML3, and THP‐1) was also significantly decreased following RCN1 knockdown using a lentiviral shRNA vector (Fig. 3B–D). The gene discussed is RCN1; the disease is acute myeloid leukemia.